Integrated Molecular Characterization of Testicular Germ Cell TumorsHui Shen, Joy C. Jayaseelan, Reanne Bowlby et al.|Cell Reports|2018Cited by 465
Regional differences observed in the phase 3 trial (ELM-PC 5) with orteronel (TAK-700) plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) that has progressed during or following docetaxel.Karim Fizazi, Robert Dreicer, Robert J. Jones et al.|Journal of Clinical Oncology|2014Cited by 3